Pilates Exercises on Balance, Fatigue and Quality of Life
31 mai 2026 mis à jour par: Mona Mohamed Amin Ziethar, Cairo University
Effect of Pilates Exercises on Balance, Fatigue and Quality of Life in Patients With Renal Transplantation
Fifty patients of both genders with age 20- 50 year old suffering from physical and functional limitations after renal transplantation surgeries participated in this study.
The participants were randomly distributed into two groups equal in number.
Group (A): 25 patients who received Pilates exercises 3 times per week in addition to conventional physical therapy program with medical care for 12 weeks while control group (group B) (n =25) who received conventional physical therapy program with medical care for 12 weeks.
Aperçu de l'étude
Statut
Recrutement
Les conditions
Intervention / Traitement
Description détaillée
Fifty patients of both genders with age 20- 50 year old suffering from physical and functional limitations after renal transplantation surgeries participated in this study.
The participants were selected from Damanhour Medical National Institute and randomly distributed into two groups equal in number.
Group (A): 25 patients who received Pilates exercises 3 times per week in addition to conventional physical therapy program with medical care for 12 weeks while control group (group B) (n =25) who received conventional physical therapy program with medical care for 12 weeks.
Outcome measures were balance, fatigue and quality of life.
Balance was evaluated by Borg Balance Scale; Fatigue was evaluated by Modified Fatigue Impact Scale and Quality of Life was evaluated by Kidney Disease Quality of Life self-report (KDQOL-SF), before and after the intervention.
Type d'étude
Interventionnel
Inscription (Estimé)
50
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Research Ethical Committee Faculty of Physical Therapy
- Numéro de téléphone: 01151312322
- E-mail: eth.com@pt.cu.edu.eg
Lieux d'étude
-
-
-
Giza, Egypte, 12613
- Pas encore de recrutement
- Faculty of Physical Therapy
-
Contact:
- Numéro de téléphone: 01151312322
- E-mail: eth.com@pt.cu.edu.eg
-
-
Beheira
-
Damanhur, Beheira, Egypte, 22511
- Recrutement
- Damanhour Medical National Institute
-
Contact:
- MONA ZIETHAR
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
(1) Patients' age was ranged between 20-50 years old, (2) Both gender participated in this study, (3) All the patients were free from any neurological disorders, (4) All the patients were free from genitourinary infections, (5) All patients started the treatment program between 3 and 12 months following renal transplantation, (6) were not currently participating in any other regular physical exercise program, (7) Patients who were able to comprehend command and willing to participate in the study and (8) Informed consent was obtained from all patients enrolled in the trial.
Exclusion Criteria:
(1) Neuropathy issues, (2) Rheumatic diseases, (3) Orthopedic diseases, (4) Abdominal surgery of the upper or lower abdomen, (5) Patients who required acute respiratory intervention, (6) Patients who transferred to the intensive care unit, (7) Active smokers, (8) uncontrolled ABP, (9) Diabetics, (10) Chronic hepatitis, (11) Patients with pacemaker, (12) detection of reduced exercise tolerance, including tachycardia, shortness of breath, and feeling too tired or weak.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Pilates exercises Plus Conventional physical therapy program.
Study group (group A) (n =25) who received Pilates exercises 3 times per week in addition to conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and already taken medical care for 12 weeks.
|
Pilates exercises consisted of three parts: warm-up, the main part, and relaxation.
During the warm-up phase, exercises aimed at improving respiration and increasing the range of motion were performed.
The main phase consisted of Pilates exercises for the center of force and strengthening of the articular, pelvic, trunk, and limb muscles by 13 exercises: Bridging, Hundred, Roll Up, One Leg Circle (both ways), Rocker with closed legs, Single Straight Leg Stretch, Double Leg Stretch, Spine Stretch Forward, Single Leg Kick, Side Kick up and down, Side Kick circles, Rest position (stretch and relaxation), and Curling.
During the relaxation phase, stretching, relaxation, and breathing exercises were performed 3 times per week for 12 weeks.
Conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and medical care (analgesics, antibiotics, wound care) for 12 weeks.
|
|
Expérimental: Conventional physical therapy program
Control group (group B) (n =25) who received conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and medical care for 12 weeks.
|
Conventional physical therapy program (aerobic walking program, low intensity strengthening Exs, stretching Exs) and medical care (analgesics, antibiotics, wound care) for 12 weeks.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Borg Balance Scale
Délai: 12 Weeks
|
The Berg Balance Scale, possibly the most widely used balance-related measure, has gained popularity in clinical trials.
It provides information about patients' balance-related abilities and can be used to assess improvement or worsening after rehabilitation.
The BBS is a scale that includes scoring between 0 (not applicable) and 4 (normal performance) for the performance of 14 different tasks.
Scores from 0 to 20 indicate a loss of balance, scores from 21 to 40 suggest an acceptable level of balance, and scores from 41 to 56 indicate good balance on this scale, which is examined across 56 points
|
12 Weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Modified Fatigue Impact Scale
Délai: 12 Weeks
|
Fatigue impact was assessed using the self-report Modified Fatigue Impact Scale (MFIS), which comprises a total score MFIS Total and three subscales (MFIS Physical, MFIS Cognitive and MFIS Psychosocial).
Higher scores indicate more fatigue impact.
The MFIS Total score (available range 0 - 84) was dichotomized at 38 to create two categories of participants, fatigued and non-fatigued
|
12 Weeks
|
|
Kidney Disease Quality of Life self-report (KDQOL-SF)
Délai: 12 Weeks
|
This questionnaire is used to assess the QOL of patients with kidney disease, It contains twenty-four questions covering a wide range of domains of human functioning in daily, occupational and social life.
It is a self-report measure, resulting from a subjective perception of one's health, functionality, and their QOL as directly related to having kidney disease.
Each answer in the questionnaire is assigned a specific number of points.
The scoring of answers in the KDQoL-SFTM questionnaire is carried out using a scale from 0 to 100 points.
The higher the value, the higher the QOL, and the lower the value, the worse the QOL.
|
12 Weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 janvier 2026
Achèvement primaire (Estimé)
1 juin 2026
Achèvement de l'étude (Estimé)
15 juin 2026
Dates d'inscription aux études
Première soumission
27 mai 2026
Première soumission répondant aux critères de contrôle qualité
31 mai 2026
Première publication (Réel)
4 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
4 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
31 mai 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 752017
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .